Skip to Main Content

Paper Details

Inhibition of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme of the nicotinamide adenine dinucleotide (NAD) salvage pathway, to target glioma heterogeneity through mitochondrial oxidative stress.
Neuro Oncol
13
2022
GSCs, IDH, KPT-9274, KPT9274, MGMT promoter, NAD, NAMPT, NHA, Tumor, Tumor cells, cell lines, glioma, glioma cell lines, glioma stem-like cells, gliomas, human, malignancies, mice, mouse, nicotinamide, nicotinamide adenine dinucleotide, nicotinamide phosphoribosyltransferase, normal human astrocytes, oxygen, tumor
Author NameAffiliation
James B ElderThe Ohio State University Wexner Medical Center
Frederick F LangThe University of Texas MD Anderson Cancer Center
Vinay K PuduvalliThe University of Texas MD Anderson Cancer Center
Vinay K PuduvalliThe Ohio State University Wexner Medical Center
  • 1 - 4

Datasets

Release 1.2